Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UCB Major Shareholding Notification 2018

Nov 21, 2018

4017_mrq_2018-11-21_17a1b02a-ea48-4ef1-9139-5ea523f2b986.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Transparency notifications BlackRock, Inc.

  • 2 notifications referring to situation on 15 and 16 November 2018
  • Threshold crossed: 5%
  • Latest holding: 5.39%

Brussels (Belgium), 21 November 2018 – 20:00 (CEST) – regulated information

1. Summary of the notifications

Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received 2 transparency notifications from BlackRock, Inc. (having its registered office at 55 East 52nd Street, New York, NY, 10055, U.S.A.), dated 16 and 19 November 2018 respectively.

In the first notification, BlackRock, Inc. has notified that, following an acquisition of UCB shares with voting rights by its affiliates, its holding in shares with voting rights of UCB SA/NV has increased and has crossed the 5% threshold on 15 November 2018.

In the second notification, BlackRock, Inc. has notified that, following a disposal of UCB shares with voting rights by its affiliates, its holding in shares with voting rights of UCB SA/NV has decreased and has crossed downwards the 5% threshold on 16 November 2018.

On 15 November 2018, BlackRock, Inc. (taking into account the holding of its affiliates) owned 9 750 349 UCB shares with voting rights (versus 9 255 186 shares in its previous notification), representing 5.01% of the total number of shares issued by the company (194 505 658) (versus 4.76% in its previous notification), as well as 736 564 equivalent financial instruments (versus 551 107 in its previous notification) representing 0.38% of the total number of shares issued by the company (versus 0.28% in its previous notification).

On 16 November 2018, BlackRock, Inc. (taking into account the holding of its affiliates) owned 9 606 869 UCB shares with voting rights, representing 4.94% of the total number of shares issued by the company, as well as 873 112 equivalent financial instruments, representing 0.45% of the total number of shares issued by the company.

2. Content of the notifications

  • 2.1 The information mentioned hereafter was identical in both notifications:
  • Reason for the notification: Acquisition or disposal of voting securities or voting rights.
  • Notification by: A parent undertaking or a controlling person.

Persons subject to the notification requirement:

Name Address (for legal entities)
BlackRock, Inc. 55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock (Netherlands) B.V. Rembrandt Tower, 17th floor, Amstelplein, Amsterdam, Netherlands
BlackRock (Singapore) Limited 20 Anson Road #18-01, Singapore, 79912, Singapore
BlackRock Advisors (UK) Limited 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Advisors, LLC 100 Bellevue Parkway, Wilmington, DE, 19809, U.S.A.
BlackRock Asset Management Canada Limited 161 Bay Street, Suite 2500, Toronto, Ontario, M5J 2S1, Canada
BlackRock Asset Management Deutschland AG Max-Joseph-Straße 6, Munich, 80333, Germany
BlackRock Asset Management North Asia Limited 15/F, 16/F, 17/F Citibank Tower & 17/F ICBC Tower, 3 Garden Road, Central,
Hong Kong
BlackRock Financial Management, Inc. 55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock Fund Advisors 400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock Institutional Trust Company, National
Association
400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock International Limited Exchange Place One, 1 Semple Street, Edinburgh, EH3 8BL, U.K.
BlackRock Investment Management (Australia)
Limited
Level 37, Chifley Tower, 2 Chifley Square, Sydney NSW 2000 Australia
BlackRock Investment Management (UK) Limited 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Investment Management, LLC 1 University Square Drive, Princeton, NJ, 8540, U.S.A.
BlackRock Japan Co., Ltd. 1-8-3 Marunouchi Chiyoda-ku, Trust Tower Main, Tokyo, 100-8217, Japan
  • Threshold crossed (in %): 5%
  • Denominator: 194 505 658.
  • Chain of controlled undertakings through which the holding is effectively held:

Please see the full chain of control in the 'Chain of Control' tab.

2.2 The first transparency notification dated 16 November 2018 included the following specific information:

Date on which the threshold is crossed: 15 November 2018.

Notified details:

A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the
securities
Linked to
securities
Not linked to the
securities
BlackRock, Inc. 0 0 0.00%
BlackRock (Netherlands) B.V. 20,158 20,742 0.01%
BlackRock (Singapore) Limited 7,282 9,219 0.00%
BlackRock Advisors (UK) Limited 1,538,717 2,004,628 1.03%
BlackRock Advisors, LLC 225,362 226,662 0.12%
BlackRock Asset Management
Canada Limited
127,585 157,975 0.08%
BlackRock Asset Management
Deutschland AG
318,467 316,633 0.16%
BlackRock Asset Management North
Asia Limited
997 997 0.00%
BlackRock Financial Management,
Inc.
202,389 174,465 0.09%
BlackRock Fund Advisors 2,404,640 2,459,465 1.26%
BlackRock Institutional Trust
Company, National Association
3,201,324 3,366,776 1.73%
BlackRock International Limited 41,345 45,446 0.02%
BlackRock Investment Management
(Australia) Limited
86,191 89,697 0.05%
BlackRock Investment Management
(UK) Limited
486,782 416,822 0.21%
BlackRock Investment Management,
LLC
306,229 320,348 0.16%
BlackRock Japan Co., Ltd. 287,718 140,474 0.07%
Subtotal 9,255,186 9,750,349 5.01%
TOTAL 9,750,349 0 5.01% 0.00%
B) Equivalent financial instruments After the transaction
Holders of equivalent
financial instruments
Type of financial instrument Expiration date Exercise period or
date
# of voting rights
that may be
acquired if the
instrument is
exercised
% of voting rights Settlement
BlackRock Advisors (UK) Limited Securities Lent 55,104 0.03% physical
BlackRock Investment Management
(UK) Limited
Securities Lent 6,698 0.00% physical
BlackRock Japan Co., Ltd. Securities Lent 41,118 0.02% physical
BlackRock Advisors (UK) Limited Contract for Difference 4,426 0.00% cash
BlackRock Advisors, LLC Contract for Difference 50,610 0.03% cash
BlackRock Financial Management,
Inc.
Contract for Difference 1,883 0.00% cash
BlackRock Institutional Trust
Company, National Association
Contract for Difference 363,006 0.19% cash
BlackRock Investment Management
(UK) Limited
Contract for Difference 74,383 0.04% cash
BlackRock Investment Management,
LLC
Contract for Difference 139,336 0.07% cash
TOTAL 736,564 0.38%
TOTAL (A & B) # of voting rights % of voting rights
CALCULATE 10,486,913 5.39%

Additional information:

The disclosure obligation arose due to shares in voting rights for BlackRock, Inc. going above 5%.

2.3. The second transparency notification dated 19 November 2018 includes the following specific information:

  • Date on which the threshold is crossed: 16 November 2018.
  • Notified details:
A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the
securities
Linked to
securities
Not linked to the
securities
BlackRock, Inc. 0 0 0.00%
BlackRock (Netherlands) B.V. 20,742 20,742 0.01%
BlackRock (Singapore) Limited 9,219 9,219 0.00%
BlackRock Advisors (UK) Limited 2,004,628 1,894,881 0.97%
BlackRock Advisors, LLC 226,662 237,505 0.12%
BlackRock Asset Management
Canada Limited
157,975 157,975 0.08%
BlackRock Asset Management
Deutschland AG
316,633 316,633 0.16%
BlackRock Asset Management North
Asia Limited
997 997 0.00%
BlackRock Financial Management,
Inc.
174,465 174,295 0.09%
BlackRock Fund Advisors 2,459,465 2,457,121 1.26%
BlackRock Institutional Trust
Company, National Association
3,366,776 3,324,327 1.71%
BlackRock International Limited 45,446 45,635 0.02%
BlackRock Investment Management
(Australia) Limited
89,697 89,697 0.05%
BlackRock Investment Management
(UK) Limited
416,822 417,020 0.21%
BlackRock Investment Management,
LLC
320,348 320,348 0.16%
BlackRock Japan Co., Ltd. 140,474 140,474 0.07%
Subtotal 9,750,349 9,606,869 4.94%
TOTAL 9,606,869 0 4.94% 0.00%
B) Equivalent financial instruments After the transaction
Holders of equivalent
financial instruments
Type of financial instrument Expiration date Exercise period or
date
# of voting rights
that may be
acquired if the
instrument is
exercised
% of voting rights Settlement
BlackRock Advisors (UK) Limited Securities Lent 140,737 0.07% physical
BlackRock Institutional Trust
Company, National Association
Securities Lent 50,308 0.03% physical
BlackRock Investment Management
(UK) Limited
Securities Lent 6,698 0.00% physical
BlackRock Japan Co., Ltd. Securities Lent 41,118 0.02% physical
BlackRock Advisors (UK) Limited Contract for Difference 4,426 0.00% cash
BlackRock Advisors, LLC Contract for Difference 51,258 0.03% cash
BlackRock Financial Management,
Inc.
Contract for Difference 1,883 0.00% cash
BlackRock Institutional Trust
Company, National Association
Contract for Difference 359,687 0.18% cash
BlackRock Investment Management
(UK) Limited
Contract for Difference 74,810 0.04% cash
BlackRock Investment Management,
LLC
Contract for Difference 142,187 0.07% cash
TOTAL 873,112 0.45%
TOTAL (A & B) # of voting rights % of voting rights
CALCULATE 10,479,981 5.39%

Additional information:

The disclosure obligation arose due to shares in voting rights for BlackRock, Inc. going below 5%.

3. Further information

This press release and the detailed transparency notifications are available on UCB SA/NV's website via the following link.

An updated overview of the UCB SA/NV large shareholdings will be available on UCB SA/NV's website via the following link.

Investor Relations

Antje Witte, Investor Relations, UCB T +32 2 559 94 14, [email protected]

About UCB

Isabelle Ghellynck, Investor Relations, UCB T +32 2 559 95 88, [email protected]

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 7 500 people in approximately 40 countries, the company generated revenue of € 4.5 billion in 2017. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news